Brain Metastases from Primary Tumors, Volume 2

Melanoma Radiation Oncology Toxicity Hormone therapy Chemotherapy Blood-brain barrier Central Nervous System Gallbladder Endothelial Cells Patient Selection Brain metastasis Breast cancer Non small cell lung Cancer Small bowel Pericytes Tyrosine kinase inhibitors Stereotactic radiosurgery E-cadherin Epidermal growth factor receptor Clinical evidence Vascular endothelial growth factor Surgical Resection Esophagectomy Targeted therapy Microenvironment Colorectal cancer Pancreatic EGFR mutation Gastrointestinal adjuvant whole-brain radiotherapy anti-VEGF treatments Basal Lamina brain metastases Brain microenvironment brain necrosis EGFR deregulation esophageal carcinoma CNS metastases HER-2 overexpression high-resolution gene expression profiling technology melanoma vascularization microvessel morphogenesis HER2 deregulation non-small cell lung carcinomas prophylactic cranial irradiation human epidermal growth factor receptor 2 recursive partitioning analysis radiosensitizing agents locoregional approach mammalian target of rapamycin inhibitors targeted systemic therapies whole-brain radiation therapy vascular endothelial growth factor receptor whole-brain radiotherapy molecular-targeted drug therapy Nasopharyngeal carcinoma palliative benefit spinal metastasis tumor response